Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Ligand Pharmaceuticals)"
Count: 37
Selected: 0
| NCT ID | Title |
|---|
| NCT04627831 | Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography | ||
| NCT02851849 | A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus | ||
| NCT02672839 | A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation | ||
| NCT02250222 | Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus | ||
| NCT01919684 | Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus | ||
| NCT00940953 | Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis | ||
| NCT00938613 | Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR | ||
| NCT00879112 | Study of MB07811 in Subjects With Hypercholesterolemia | ||
| NCT00674453 | The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation | ||
| NCT00635232 | A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension | ||
| NCT00626418 | The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome | ||
| NCT00623324 | The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease | ||
| NCT00522925 | A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension | ||
| NCT00458016 | Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus | ||
| NCT00163137 | Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss | ||
| NCT00143273 | Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation | ||
| NCT00141323 | Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL) | ||
| NCT00073736 | Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma | ||
| NCT03869983 | Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection and Omnipaque™ Injection | ||
| NCT00006345 | Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma | ||
| NCT00003752 | Bexarotene in Treating Patients With Metastatic Breast Cancer | ||
| NCT00002212 | A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma | ||
| NCT04629976 | Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B | ||
| NCT00151008 | Bexarotene With Narrow-Band UVB for Psoriasis | ||
| NCT00322296 | Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis | ||
| NCT00306969 | Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma | ||
| NCT00063076 | Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata | ||
| NCT00002439 | A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma | ||
| NCT00002188 | A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma | ||
| NCT04309526 | Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects | ||
| NCT00238628 | A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer | ||
| NCT00125372 | Study of Tarceva and Targretin in Stage I-II Lung Cancer | ||
| NCT00125359 | Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer | ||
| NCT01116622 | Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract | ||
| NCT00153842 | A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer | ||
| NCT01128959 | Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy | ||
| NCT00211198 | Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) |
